The company has a balanced portfolio of clinical development stage as well as research stage products, and aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. Axsome Therapeutics is committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians, and evaluates potential in-licensing opportunities to supplement its current portfolio.